Cosmos Health contract manufacturing unit orderbook tops 25 million units

Cosmos Health Inc

Cosmos Health Inc

COSM

0.00
  • Cosmos Health reported a contract-manufacturing orderbook above 25 million units through its Cana Laboratories unit.
  • Agreements run up to 10 years, supporting recurring revenue visibility across nine therapeutic categories.
  • Management expects the contract-manufacturing division to generate more than $10 million in recurring annual profit at full capacity.
  • Production is based at Cana’s 54,000-square-foot EU-GMP, EMA-certified Athens facility following about $5.5 million in upgrades.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606221030OMX_____CNEWS_EN_GNW9750392_en) on June 22, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.